Advantages of sensor-augmented insulin pump therapy for pregnant women with type 1 diabetes mellitus

1. Persson M, Norman M, Hanson U. Obstetric and perinatal

outcomes in type 1 diabetic pregnancies: a large,

population-based study. Diabetes Care 2009; 32: 2005–2009.

2. Holmes VA, Young IS, Patterson CC, et al. Optimal glycemic

control, pre-eclampsia, and gestational hypertension in

women with type 1 diabetes in the diabetes and preeclampsia intervention trial. Diabetes Care 2011; 34: 1683–

1688.

3. Maresh MJ, Holmes VA, Patterson CC, et al. Glycemic

targets in the second and third trimester of pregnancy

for women with type 1 diabetes. Diabetes Care 2015; 38:

34–42.

4. Feig DS, Corcoy R, Donovan LE, et al. Pumps or multiple

daily injections in pregnancy involving type 1 diabetes: a

prespecified analysis of the CONCEPTT randomized trial.

Diabetes Care 2018; 41: 2471–2479.

5. Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose

monitoring in pregnant women with type 1 diabetes

(CONCEPTT): a multicentre international randomised

controlled trial. Lancet (London, England) 2017; 390: 2347–

2359.

6. Bergenstal RM, Tamborlane WV, Ahmann A, et al.

Effectiveness of sensor-augmented insulin-pump therapy in

type 1 diabetes. N Engl J Med 2010; 363: 311–320.

7. Hermanides J, Nørgaard K, Bruttomesso D, et al. Sensoraugmented pump therapy lowers HbA(1c) in suboptimally

controlled type 1 diabetes; a randomized controlled trial.

Diabet Med 2011; 28: 1158–1167.

8. Minakami H, Hiramatsu Y, Koresawa M, et al. Guidelines for

obstetrical practice in Japan: Japan Society of Obstetrics and

Gynecology (JSOG) and Japan Association of Obstetricians

and Gynecologists (JAOG) 2011 edition. J Obstet Gynaecol

Res 2011; 37: 1174–1197.

9. Minakami H, Maeda T, Fujii T, et al. Guidelines for obstetrical

practice in Japan: Japan Society of Obstetrics and

Gynecology (JSOG) and Japan Association of Obstetricians

and Gynecologists (JAOG) 2014 edition. J Obstet Gynaecol

Res 2014; 40: 1469–1499.

10. Itakura A, Shoji S, Shigeru A, et al. Guidelines for obstetrical

practice in Japan: Japan Society of Obstetrics and

Gynecology and Japan Association of Obstetricians and

Gynecologists 2020 edition. J Obstet Gynaecol Res 2023; 49:

5–53.

11. Kashiwagi A, Kasuga M, Araki E, et al. International clinical

harmonization of glycated hemoglobin in Japan: from

Japan Diabetes Society to National Glycohemoglobin

J Diabetes Investig Vol. 14 No. 12 December 2023

1389

20401124, 2023, 12, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jdi.14075 by Kobe University, Wiley Online Library on [30/11/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

http://wileyonlinelibrary.com/journal/jdi

12.

13.

14.

15.

16.

17.

18.

19.

Standardization Program values. J Diabetes Investig 2012; 3:

39–40.

Watanabe K, Matsubara K, Nakamoto O, et al. Outline of the

new definition and classification of “hypertensive disorders

of pregnancy (HDP)”; a revised JSSHP statement of 2005.

Hypertens Res Pregnancy 2018; 6: 33–37.

Itabashi K, Fujimura M, Kusuda S, et al. New normative

birthweight among Japanese infants according to

gestational week at delivery. Acta Paediatr Jpn 2010; 114:

1271–1293 (in Japanese).

Nakamura H, Yonetani M, Uetani Y, et al. Determination of

serum unbound bilirubin for prediction of kernicterus in

low birthweight infants. Acta Paediatr Jpn 1992; 34: 642–647.

Morioka I, Nakamura H. Treatment criteria for infants with

hyperbilirubinemia in Japan. Semin Perinatol 2021; 45:

151352.

Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for

continuous glucose monitoring data interpretation:

recommendations from the international consensus on

time in range. Diabetes Care 2019; 42: 1593–1603.

Chico A, Herranz L, Corcoy R, et al. Glycemic control and

maternal and fetal outcomes in pregnant women with type

1 diabetes according to the type of basal insulin. Eur J

Obstet Gynecol Reprod Biol 2016; 206: 84–91.

s M, Kosin

ski M, Kuchnicka A, et al. Continuous

Zurawska-Kli

subcutaneous insulin infusion does not correspond with

pregnancy outcomes despite better glycemic control as

compared to multiple daily injections in type 1 diabetes –

significance of pregnancy planning and prepregnancy

HbA1c. Diabetes Res Clin Pract 2021; 172: 108628.

Kallas-Koeman MM, Kong JM, Klinke JA, et al. Insulin pump

use in pregnancy is associated with lower HbA1c without

increasing the rate of severe hypoglycaemia or diabetic

1390

J Diabetes Investig Vol. 14 No. 12 December 2023

http://wileyonlinelibrary.com/journal/jdi

20.

21.

22.

23.

24.

25.

26.

ketoacidosis in women with type 1 diabetes. Diabetologia

2014; 57: 681–689.

Hauffe F, Schaefer-Graf UM, Fauzan R, et al. Higher rates of

large-for-gestational-age newborns mediated by excess

maternal weight gain in pregnancies with type 1 diabetes

and use of continuous subcutaneous insulin infusion vs

multiple dose insulin injection. Diabet Med 2019; 36: 158–

166.

Bruttomesso D, Bonomo M, Costa S, et al. Type 1 diabetes

control and pregnancy outcomes in women treated with

continuous subcutaneous insulin infusion (CSII) or with

insulin glargine and multiple daily injections of rapid-acting

insulin analogues (glargine-MDI). Diabetes Metab 2011; 37:

426–431.

Matsuoka A, Hirota Y, Urai S, et al. Effect of switching from

conventional continuous subcutaneous insulin infusion to

sensor augmented pump therapy on glycemic profile in

Japanese patients with type 1 diabetes. Diabetol Int 2018; 9:

201–207.

Katayama A, Tone A, Watanabe M, et al. The hypoglycemiaprevention effect of sensor-augmented pump therapy with

predictive low glucose management in Japanese patients

with type 1 diabetes mellitus: a short-term study. Diabetol

Int 2020; 11: 97–104.

Kuroda A, Kaneto H, Yasuda T, et al. Basal insulin

requirement is ~30% of the total daily insulin dose in type

1 diabetic patients who use the insulin pump. Diabetes Care

2011; 34: 1089–1090.

Nakamura T, Hirota Y, Hashimoto N, et al. Diurnal variation

of carbohydrate insulin ratio in adult type 1 diabetic

patients treated with continuous subcutaneous insulin

infusion. J Diabetes Investig 2014; 5: 48–50.

Beutler E. G6PD deficiency. Blood 1994; 84: 3613–3636.

ª 2023 The Authors. Journal of Diabetes Investigation published by AASD and John Wiley & Sons Australia, Ltd

20401124, 2023, 12, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jdi.14075 by Kobe University, Wiley Online Library on [30/11/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

ORIGINAL ARTICLE

Imafuku et al.

...